GNPX
Genprex IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.39M
P/E Ratio
—
EPS
$-17.40
Beta
-0.67
52W High
$55.00
52W Low
$1.32
50-Day MA
$2.04
200-Day MA
$6.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Genprex Inc
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-15.51M |
| Operating Margin | 0.00% |
| Return on Equity | -338.70% |
| Return on Assets | -135.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.78 |
| Price-to-Book | 0.45 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.18 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $9.04M |
| Float | $8.96M |
| % Insiders | 1.14% |
| % Institutions | 0.23% |
Data last updated: 4/8/2026